pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Jul 16·2 min read
save

Convenience Kit Correction: Arrow International Issues Correction for Convenience Kits Containing Recalled Huons Lidocaine and Bupivacaine and Saline

Saline, Lidocaine and Bupivacaine from affected convenience kits should not be used.

Jul 16, 2026·read at fda medwatch ↗

This recall involves correcting certain devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.Affected Product The FDA is aware that Arrow International has issued a letter to affected customers recommending certain convenience kits be corrected prior to continued use.

Affected devices:Arrow Kits and Sets that contain 0.9% sodium chloride (10mL saline solution ampule) and Lidocaine Arrow Kits and Sets containing Lidocaine and BupivacaineFull list of affected productsWhat to DoDo not use the affected saline ampule and lidocaine included in affected Arrow kits.On April 2026, Arrow International sent all affected customers a letter recommending the following actions:Do not use the affected 0.9% sodium chloride (10mL saline ampule) and lidocaine included in affected Arrow kits. Do not use the Lidocaine and Bupivacaine in the kits.At the point of use, discard the affected saline, lidocaine and bupivacaine ampules upon opening the kit.Obtain 0.9% sodium chloride (saline solution), bupivacaine and lidocaine separately through your facility pharmacy and prepare / administer it per institutional protocols prior to the procedure.Ensure all relevant personnel in your organization are informed of this notice.Reason for CorrectionArrow International, a Teleflex subsidiary, is removing saline, bupivacaine and lidocaine ampules manufactured by Huons Co. Ltd from certain convenience kits.

Huons Co., Ltd. initiated a recall of saline, bupivacaine and lidocaine.Risks of using compromised injectables include infection, inflammatory response and/or reduced or lack of anesthetic effectiveness. Use of Lidocaine or bupivacaine with reduced or lack of anesthetic effectiveness, may result in ineffective pain control leading to varying degrees of pain, surgical complications, such as emergency conversion and/or repeat or delayed treatment, and/or patient distress.As of April 20, 2026, Arrow International has reported no serious injuries and no deaths associated with this issue.Device UseConvenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components that are intended to be used during various surgical procedures.Contact InformationCustomers in the U.S.

with adverse reactions, quality problems, or questions about this recall should contact Arrow International at Recalls@teleflex.com or 1-866-396-2111.Additional FDA ResourcesFDA Enforcement ReportCDRH Medical Device Recall Database Huons Co., Ltd. Saline and Lidocaine Recall: FDA Enforcement ReportAnesthesia Kit Correction: Becton Dickinson Issues Correction for BD Spinal Trays Containing Bupivacaine Ampules | FDA [06/03/2026]Additional Company ResourcesCompany-provided information is posted here by the FDA as a public service.Teleflex Recall Webpage [04/15/2026]Unique Device Identifier (UDI)The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.How do I recognize a UDI on a label?AccessGUDID database - Identify Your Medical DeviceBenefits of a UDI SystemHow do I report a problem?Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

source

Reporting by fda medwatch.

read at fda medwatch ↗
508 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5d agoEarly Alert: Percutaneous Catheter Issue from Boston Scientificfda medwatch
  • Jul 20Early Alert: Intravascular Administration Set Issue from Baxterfda medwatch
  • Jul 17Catheter Introducer Kit Recall: Abiomed Removes 14Fr Low Profile Introducer Kitsfda medwatch
  • Jul 17Thoracic Stent Graft Recall: Bolton Medical Removes Relay Pro Systemfda medwatch
  • Jul 16Convenience Kit Recall: B. Braun Medical, Inc. Removes Spinal Anesthesia Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USPfda medwatch